For instance, the quantitative measurement of CD3+ T cells within the tumour core and invasive margin has been useful in predicting clinical responses to treatment in patients with colorectal cancer [309], while other work has shown that an absence of intra-tumoural PD-L1 expression is more likely to blunt the therapeutic effects of αPD-1 ICB [310]. This evidence concerns the gene CD274 and neoplasm.